Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/I5X stock hub

FRA/I5X has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/I5Xis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.3B

Frankfurt Stock Exchange

Market data

Price

Recent price action with selectable time range.

FRA/I5XFRA/I5X

—

Loading chart…

In the news

Latest news · FRA/I5X

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-572

P25 n/aP50 n/aP75 n/a

ROIC-69.6

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/I5X market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

162

Groups with data

Currency

USD

Showing 162 of 162 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	160
Employees Change	-59%
Employees Change Percent	-29.21
Enterprise value	EUR 1.3B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 1.3B
Price	EUR 3.54
Price currency	EUR
Rev Per Employee	51,549.14x
Sic	2836
Symbol	fra/I5X
Website	https://precigen.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-28.91%
EV Earnings	-3.46x
EV/FCF	-16.55x
EV/Sales	153.91x
FCF yield	-6.04%
P/B ratio	71.08x
P/S ratio	153.49x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	EUR -31.1M
Net Income	EUR -365.9M
Pretax Margin	-2,588.18%
Profit Per Employee	EUR -2.3M
ROA	-44.3
Roa5y	-29.54
ROCE	-90.19
ROE	-572
Roe5y	-196.4
ROIC	-69.61

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-17.04%
Cagr1y	194.24%
Cagr3y	48.08%
Cagr5y	-8.01%
Revenue Growth	146.73x
Revenue Growth Q	283.61x
Revenue Growth3 Y	-28.87x
Revenue Growth5 Y	-21.26x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.06
Assets	EUR 132.4M
Cash	EUR 83.3M
Current Assets	EUR 97.7M
Current Liabilities	EUR 31.6M
Debt	EUR 83.7M
Debt Equity	EUR 4.7
Debt FCF	EUR -1.09
Equity	EUR 17.8M
Interest Coverage	-27.57
Liabilities	EUR 114.6M
Long Term Assets	EUR 34.7M
Long Term Liabilities	EUR 83M
Net Cash	EUR -367,934
Net Cash By Market Cap	EUR -0.03
Net Debt Equity	EUR 0.02
Tangible Book Value	EUR 2.1M
Tangible Book Value Per Share	EUR 0.01

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.09
Net Working Capital	EUR -16M
Quick ratio	2.74
Working Capital	EUR 66.4M
Working Capital Turnover	EUR 0.1

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-16.9%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-84.56%
1Y total return	194.02%
200-day SMA	3.19
3Y total return	224.77%
50-day SMA	3.19
50-day SMA vs 200-day SMA	50under200
5Y total return	-34.14%
All Time High	62.15
All Time High Change	-94.3%
All Time High Date	2015-08-05
All Time Low	0.63
All Time Low Change	464.14%
All Time Low Date	2024-12-17
ATR	0.14
Ch YTD	-4.74
High	3.54
High52	4.55
High52 Date	2026-02-17
High52ch	-22.23%
Low	3.54
Low52	1.08
Low52 Date	2025-05-08
Low52ch	229.3%
Ma50ch	11.01%
Price vs 200-day SMA	11.01%
RSI	56.7
RSI Monthly	61.99
RSI Weekly	54.33
Sharpe ratio	1.42x
Sortino ratio	3.09
Total Return	-16.9%
Tr YTD	-4.74
Tr1m	1.72%
Tr1w	4.43%
Tr3m	-2.75%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -90.8M
Operating margin	-1,100.8

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	168,880,265%
Net Borrowing	78,706,136.9
Shares Insiders	11.89%
Shares Institutions	34.97%
Shares Qo Q	15.34%
Shares Yo Y	16.9%
Short Ratio	8.83

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -86.2M
Average Volume	154.2x
Bv Per Share	0.05
CAPEX	EUR -1.7M
Ch10y	-84.56
Ch1m	1.72
Ch1w	4.43
Ch1y	194
Ch3m	-2.75
Ch3y	224.8
Ch5y	-34.14
Ch6m	11.53
Change	2.61%
Change From Open	0
Close	3.45
Days Gap	2.61
Depreciation Amortization	2,712,630.4
Earnings Date	2026-05-13
EBIT	EUR -90.8M
EBITDA	EUR -88.1M
EPS	EUR -1.17
F Score	3
FCF	EUR -76.5M
FCF EV Yield	-6.04x
Financing CF	76,693,882
Fiscal Year End	December
Founded	1,998
Goodwill	12,916,157.2
Income Tax	EUR 2,555
Investing CF	-1,307,360
Is Primary Listing	0
Last Earnings Date	2026-03-25
Last Report Date	2025-12-31
Ma150	3.36
Ma150ch	5.33%
Ma20	3.41
Ma20ch	3.84%
Net CF	610,669
Next Earnings Date	2026-05-13
Open	3.54
Ppne	15,633,875.4
Price Date	2026-05-08
Ptbv Ratio	595.3
Relative Volume	3.87x
Revenue	8,247,863x
SBC By Revenue	117.65x
Share Based Comp	9,703,418
Tax By Revenue	0.03x
Tr6m	11.53%
Volume	0
Z Score	-19.32

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/I5X pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/I5X stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/I5X?

Insider, institutional, and short-interest positioning.

Institutional ownership

+35.0%

Share of float held by funds and institutions

Insider ownership

+11.9%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/I5X momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

56.7

Neutral momentum band

Price vs 200-day MA

+11.0%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.42

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/I5X

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/I5X stock rating?

fra/I5X is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/I5X analysis?

The full report lives at /stocks/fra/I5X/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/I5X?

The latest report frames fra/I5X around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/I5X page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.